|
⚲
|
| Keyboard |
| Chereau Frederic
✚
|
|
|---|---|
| CIK # | 0001640592 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001640592] | |
| 4 | [0001640592] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| LogicBio Therapeutics Inc | |
| Chereau Frederic | |
| aTYR Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
LogicBio Therapeutics Inc LOGC
Common Stock
|
2022-11-16 | Disposed to issuer | 253,811 | ||
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2022-11-16 | Disposed to issuer | 547,000 | ||
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2022-11-16 | Disposed to issuer | 328,000 | ||
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2022-03-01 | Grant | 328,000 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Common Stock
|
2021-04-16 | Sell | 7,542 | $5.73 | 43,216 |
|
LogicBio Therapeutics Inc LOGC
Restricted Stock Units · derivative
|
2021-04-15 | Option exercise | 23,414 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Common Stock
|
2021-04-15 | Option exercise | 23,414 | ||
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2021-02-23 | Grant | 282,804 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Restricted Stock Units · derivative
|
2020-04-15 | Grant | 23,414 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Stock Option (right to buy) · derivative
|
2020-02-11 | Grant | 222,000 | $0.00 | |
|
LogicBio Therapeutics Inc LOGC
Employee Stock Option (right to buy) · derivative
|
2018-10-18 | Grant | 212,525 | $0.00 | |
|
aTYR Pharma Inc LIFE
Stock Option (right to buy) · derivative
|
2015-05-06 | Grant | 22,001 |